Paul, Weiss Adds Leading Employee Benefits Partner

Paul, Weiss, Rifkind, Wharton & Garrison LLP announced today that Jean M. McLoughlin is joining the firm as a partner in the Employee Benefits & Executive Compensation practice, resident in the New York office. Ms. McLoughlin’s practice focuses on compensation and benefits aspects of public company M&A and private equity transactions, as well as related corporate governance matters.

“We are pleased to welcome Jean, who is one of the nation’s leading executive compensation attorneys,” said Paul, Weiss Chairman Brad S. Karp. “Our increasing volume of public company M&A and private equity transactions demands sophisticated compensation and benefits advice that Jean is uniquely positioned to provide to our clients.”

Ms. McLoughlin advises corporate, financial and individual clients and compensation committees on the negotiation of employment and compensation arrangements, including equity incentive plans, and their securities and tax implications. Ms. McLoughlin also advises on compensation disclosure and board executive compensation oversight.

“Jean brings an impressive track record, deep knowledge and versatility in the vitally important areas of compensation and incentives,” said Robert B. Schumer, chair of the firm’s Corporate Department. “She’s a great cultural fit, and we look forward to collaborating with her as our partner.”

“Jean is a talented lawyer who provides thoughtful, trusted advice on the executive compensation aspects of complex public M&A deals,” said Scott A. Barshay, global head of the firm’s Mergers & Acquisitions Practice. “With her commitment to client service and her reputation for excellence, she will be a fantastic addition to our firm.”

Ms. McLoughlin has handled the benefits and compensation issues and negotiations connected with some of the world’s most significant public company and private equity deals, including Cigna in its $3.8 billion acquisition of Healthspring; Conagra Foods in its $6.8 billion acquisition of Ralcorp and in its $2.7 billion sale of its private brands business to Treehouse Foods; the Ferrero Group in its $2.8 billion acquisition of the U.S. confectionery business of Nestlé; Lockheed Martin in its $9 billion acquisition of Sikorsky from United Technologies; and Roche in numerous multibillion-dollar acquisitions, including its $46.8 billion acquisition of Genentech, $8.3 billion acquisition of InterMune and $2.4 billion acquisition of Foundation Medicine.

Ms. McLoughlin earned a B.A., summa cum laude, from Yale College, and a J.D., cum laude, from Harvard Law School. Following law school, she clerked for the Honorable J. Spencer Letts in the U.S. District Court for the Central District of California.